EAM-2201
外观
![]() | |
法律规范状态 | |
---|---|
法律规范 |
|
识别信息 | |
| |
CAS号 | 1364933-60-7 ![]() |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
化学信息 | |
化学式 | C26H26FNO |
摩尔质量 | 387.50 g·mol−1 |
3D模型(JSmol) | |
| |
|
EAM-2201,化学名1-(5-氟戊基)-3-(4-乙基-1-萘甲酰基)吲哚,也称为4'-ethyl-AM-2201、5"-fluoro-JWH-210、SGT-14)是一种含氮有机氟化合物,化学式C
26H
26FNO,属于萘甲酰基吲哚类合成大麻素[2],2015年列入《非药用类麻醉药品和精神药品名录》[3]。
参考文献
[编辑]- ^ Anvisa. RDC Nº 804 – Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial [Collegiate Board Resolution No. 804 – Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control]. Diário Oficial da União. 2023-07-24 (2023-07-25) [2023-08-27]. (原始内容存档于2023-08-27) (巴西葡萄牙语).
- ^ Kim JH, Kim HS, Kong TY, Lee JY, Kim JY, In MK, Lee HS. In vitro metabolism of a novel synthetic cannabinoid, EAM-2201, in human liver microsomes and human recombinant cytochrome P450s. Journal of Pharmaceutical and Biomedical Analysis. February 2016, 119 (5): 50–8. PMID 26641707. doi:10.1016/j.jpba.2015.11.023.
- ^ 关于印发《非药用类麻醉药品和精神药品列管办法》的通知. China Food and Drug Administration. 27 September 2015 [1 October 2015] (Chinese).